Please login to the form below

Not currently logged in
Email:
Password:

European Hematology Association

This page shows the latest European Hematology Association news and features for those working in and with pharma, biotech and healthcare.

J&J’s Darzalex shows ‘significant’ survival benefit in newly diagnosed multiple myeloma

J&J’s Darzalex shows ‘significant’ survival benefit in newly diagnosed multiple myeloma

Johnson &Johnson’s CD38 monoclonal antibody (mAb) Darzalex has achieved ‘significant’ overall survival (OS) data in newly diagnosed multiple myeloma, the company revealed at the European Hematology Association 2021 virtual congress

Latest news

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....